ropivacaine has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, QL; He, X; Peng, QY; Zou, Y | 1 |
| Huang, Z; Liu, G; Shan, R; Sun, C; Wang, G; Wang, L; Zhang, X; Zhong, Y | 1 |
1 trial(s) available for ropivacaine and malondialdehyde
| Article | Year |
|---|---|
Assessment of the effect of perineural dexmedetomidine on oxidative stress during peritoneal dialysis catheter insertion: a randomized, controlled trial.
Topics: Anesthetics, Local; Catheters; Dexmedetomidine; Glutathione Peroxidase; Humans; Kidney Failure, Chronic; Malondialdehyde; Nerve Block; Oxidative Stress; Peritoneal Dialysis; Prospective Studies; Ropivacaine; Superoxide Dismutase; Ultrasonography, Interventional | 2022 |
1 other study(ies) available for ropivacaine and malondialdehyde
| Article | Year |
|---|---|
Inhibition of CD38/Cyclic ADP-ribose Pathway Protects Rats against Ropivacaine-induced Convulsion.
Topics: ADP-ribosyl Cyclase 1; Amides; Animals; Calcium Signaling; Cyclic ADP-Ribose; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ropivacaine; Seizures; Signal Transduction; Superoxide Dismutase | 2017 |